{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:17:11Z","timestamp":1791274631898,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12350-019-01755-3","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T15:03:07Z","timestamp":1560438187000},"page":"1414-1433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis\u20142018 update: Japanese Society of Nuclear Cardiology recommendations"],"prefix":"10.1016","volume":"26","author":[{"given":"Shinichiro","family":"Kumita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokuo","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Naya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-019-01755-3_bib1","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-019-01755-3_bib2","unstructured":"O\u2019Regan A, Berman JS. Sarcoidosis. Ann Intern Med 2012;156:ITC5-1, ITC5-2, ITC5-3, ITC5-4, ITC5-5, ITC5-6, ITC5-7, ITC5-8, ITC5-9, ITC5-10, ITC5-11, ITC5-12, ITC5-13, ITC5-14, ITC5-15; quiz ITC5-16."},{"key":"10.1007\/s12350-019-01755-3_bib3","first-page":"325","article-title":"Sarcoidosis: a review for the internist","volume":"13","author":"Bargagli","year":"2018","journal-title":"Intern Emerg Med"},{"key":"10.1007\/s12350-019-01755-3_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01755-3_bib5","series-title":"Guidelines for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary disease (in Japanese)","first-page":"2","author":"Hiraga","year":"1993"},{"key":"10.1007\/s12350-019-01755-3_bib6","unstructured":"Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord [in Japanese] 2007;27:89-102."},{"key":"10.1007\/s12350-019-01755-3_bib7","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"key":"10.1007\/s12350-019-01755-3_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.17996\/anc.17-00027","article-title":"Clinical application of 18F-fluorodeoxyglucose PET and LGE CMR in cardiac sarcoidosis","volume":"3","author":"Ohira","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","article-title":"Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy","volume":"10","author":"Patel","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01755-3_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-019-01755-3_bib11","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","volume":"28","author":"Cooper","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-019-01755-3_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01755-3_bib14","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: A focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib15","first-page":"1571","article-title":"Comparative evaluation of 18F-FDG PET and 67 Ga scintigraphy in patients with sarcoidosis","volume":"47","author":"Nishiyama","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.18-00070","article-title":"Updated Japanese Ministry of Health, Labour and Welfare Reimbursement Policy for Cardiac Positron Emission Tomography and Coronary Intervention","volume":"4","author":"Yoshinaga","year":"2018","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12350-015-0136-1","article-title":"Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence","volume":"22","author":"Yoshinaga","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.17996\/anc.17-00029","article-title":"Japanese Guidelines for Cardiac Sarcoidosis","volume":"3","author":"Yoshinaga","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.17996\/anc.17-00044","article-title":"Roles of 18F-FDG PET in diagnosis and management of cardiac sarcoidosis\u2014from the continuing medical education session at the 63rd SNMMI meeting, June 2016","volume":"3","author":"Tamaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.copbio.2006.11.003","article-title":"Imaging myocardial metabolism","volume":"18","author":"Yoshinaga","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"10.1007\/s12350-019-01755-3_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI112820","article-title":"Myocardial metabolism of free fatty acids Studies with 14C-labeled substrates in humans","volume":"79","author":"Wisneski","year":"1987","journal-title":"J Clin Investig"},{"key":"10.1007\/s12350-019-01755-3_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.17996\/anc.17-00037","article-title":"Optimal patient preparation for detection and assessment of cardiac sarcoidosis by FDG-PET","volume":"3","author":"Miyagawa","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib25","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-011-1832-y","article-title":"(1)(8)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"38","author":"Ohira","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01755-3_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01755-3_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-4-1","article-title":"Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis","volume":"4","author":"Morooka","year":"2014","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-019-01755-3_bib30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12350-017-1122-6","article-title":"Volume-based glucose metabolic analysis of FDG PET\/CT: The optimum threshold and conditions to suppress physiological myocardial uptake","volume":"26","author":"Manabe","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib32","first-page":"1227","article-title":"Procedure guideline for SPECT\/CT imaging 1.0","volume":"47","author":"Delbeke","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1095-0397(01)00062-0","article-title":"Reduction of myocardial 2-deoxy-2-[18F]fluoro-d-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction","volume":"4","author":"Lum","year":"2002","journal-title":"Mol Imaging Biol"},{"key":"10.1007\/s12350-019-01755-3_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12350-009-9179-5","article-title":"Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial","volume":"17","author":"Cheng","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2013.05.004","article-title":"Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet","volume":"62","author":"Kobayashi","year":"2013","journal-title":"J Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib36","doi-asserted-by":"crossref","first-page":"W151","DOI":"10.2214\/AJR.07.2409","article-title":"Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet","volume":"190","author":"Williams","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1007\/s12350-019-01755-3_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","article-title":"Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis","volume":"195","author":"Yokoyama","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib38","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1253\/circj.CJ-15-0681","article-title":"Diagnosis and detection of myocardial injury in active cardiac sarcoidosis-significance of myocardial fatty acid metabolism and myocardial perfusion mismatch","volume":"79","author":"Momose","year":"2015","journal-title":"Circ J"},{"key":"10.1007\/s12350-019-01755-3_bib39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2169\/internalmedicine.50.4813","article-title":"Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography","volume":"50","author":"Ohira","year":"2011","journal-title":"Intern Med"},{"key":"10.1007\/s12350-019-01755-3_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.108.055616","article-title":"Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET\/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation","volume":"50","author":"Wykrzykowska","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib41","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1042\/bst0311115","article-title":"The glucose-fatty acid cycle: a physiological perspective","volume":"31","author":"Frayn","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1007\/s12350-019-01755-3_bib42","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12350-017-1100-z","article-title":"Patient page-sarcoidosis imaging","volume":"26","author":"Bois","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib44","first-page":"1","article-title":"Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin)","volume":"724","author":"Persson","year":"1988","journal-title":"Acta Med Scand Supplement"},{"key":"10.1007\/s12350-019-01755-3_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1056\/NEJM199001253220403","article-title":"Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy","volume":"322","author":"Shulman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-019-01755-3_bib46","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI115780","article-title":"Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo","volume":"89","author":"Nuutila","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1007\/s12350-019-01755-3_bib47","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-019-01755-3_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01755-3_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2125.1979.tb01000.x","article-title":"A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects","volume":"7","author":"Asmal","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1007\/s12350-019-01755-3_bib50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2967\/jnumed.115.166884","article-title":"Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in (1)(8)F-FDG PET imaging","volume":"57","author":"Scholtens","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib51","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2967\/jnumed.114.138594","article-title":"A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: Implications for vulnerable coronary plaque imaging","volume":"55","author":"Demeure","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12350-015-0252-y","article-title":"Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis","volume":"23","author":"Bois","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib53","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.104.518563","article-title":"When heparins promote thrombosis: Review of heparin-induced thrombocytopenia","volume":"111","author":"Jang","year":"2005","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01755-3_bib54","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1007\/s12350-019-01755-3_bib55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ajh.20849","article-title":"Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes","volume":"82","author":"Muslimani","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1007\/s12350-019-01755-3_bib56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.2011.08746.x","article-title":"Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients","volume":"154","author":"Kato","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1007\/s12350-019-01755-3_bib57","first-page":"391","article-title":"PET\/CT Practice guidelines 2012, September 2012 by Japanese Society of Nuclear Medicine","volume":"49","author":"Fdg","year":"2012","journal-title":"Kaku Igaku"},{"key":"10.1007\/s12350-019-01755-3_bib58","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib59","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.nuclcard.2006.08.009","article-title":"Positron emission tomography myocardial perfusion and glucose metabolism imaging","volume":"13","author":"Machac","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12350-010-9244-0","article-title":"Recommendations for reducing radiation exposure in myocardial perfusion imaging","volume":"17","author":"Cerqueira","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.17996\/anc.18-00071","article-title":"Present status of medical radiation and nuclear cardiology usage in Japan: A Discussion at the American Society of Nuclear Cardiology Joint Symposium","volume":"4","author":"Kudo","year":"2018","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib62","first-page":"1358","article-title":"A mathematical model for the distribution of fluorodeoxyglucose in humans","volume":"40","author":"Hays","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib63","first-page":"1664","article-title":"PET\/CT: challenge for nuclear cardiology","volume":"46","author":"Schwaiger","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib64","first-page":"436","article-title":"Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET\/CT?","volume":"46","author":"DiFilippo","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00259-010-1635-6","article-title":"Is metal artefact reduction mandatory in cardiac PET\/CT imaging in the presence of pacemaker and implantable cardioverter defibrillator leads?","volume":"38","author":"Ghafarian","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01755-3_bib66","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01755-3_bib67","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib68","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib69","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCHEARTFAILURE.112.969261","article-title":"Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression","volume":"6","author":"Kandolin","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1007\/s12350-019-01755-3_bib71","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1007\/s12350-019-01755-3_bib72","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1007\/s12350-019-01755-3_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1007\/s12350-019-01755-3_bib74","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s00259-013-2460-5","article-title":"Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis","volume":"40","author":"Manabe","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01755-3_bib75","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.1007\/s12350-019-01755-3_bib76","first-page":"178","article-title":"Sarcoidosis presenting as heart disease","volume":"13","author":"Nelson","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1007\/s12350-019-01755-3_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib78","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/echo.13163","article-title":"Right heart involvement in patients with sarcoidosis","volume":"33","author":"Patel","year":"2016","journal-title":"Echocardiography"},{"key":"10.1007\/s12350-019-01755-3_bib79","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2967\/jnumed.116.187203","article-title":"Inter- and intraobserver agreement of (18)F-FDG PET\/CT image interpretation in patients referred for assessment of cardiac sarcoidosis","volume":"58","author":"Ohira","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib80","first-page":"784","article-title":"Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues","volume":"45","author":"Paquet","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.17996\/anc.17-00015","article-title":"Qualitative and quantitative assessments of cardiac sarcoidosis using 18F-FDG PET","volume":"3","author":"Manabe","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib82","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib84","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib85","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1007\/s12350-019-01755-3_bib86","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.amjcard.2015.01.562","article-title":"Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.17996\/anc.17-00023","article-title":"Clinical management of cardiac sarcoidosis","volume":"3","author":"Birnie","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib88","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s12350-014-9921-5","article-title":"Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"21","author":"Waller","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib89","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib90","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2003.05.012","article-title":"The role of iodine-123-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis","volume":"94","author":"Kaminaga","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib91","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12149-016-1136-1","article-title":"Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging","volume":"31","author":"Kataoka","year":"2017","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib92","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s12350-017-1131-5","article-title":"Radiopharmaceutical tracers for cardiac imaging","volume":"25","author":"Manabe","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01755-3_bib93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","article-title":"Semi-quantitative metabolic values on FDG PET\/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis","volume":"7","author":"Ishiyama","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-019-01755-3_bib94","first-page":"188","article-title":"Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects","volume":"36","author":"Bartlett","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib95","first-page":"1749","article-title":"Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans","volume":"31","author":"Gropler","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01755-3_bib96","unstructured":"Shinichiro S, Yoshinaga K, Miyagawa M et al. \u5fc3\u81d3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306b\u5bfe\u3059\u308b18F-FDG PET\u691c\u67fb\u306e\u624b\u5f15\u304d 2018\u5e74\u6539\u8a02. Shinzo-Kaku-Igaku 21:22-27. https:\/\/doi.org\/10.14951\/jsnc.21-001."}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-019-01755-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123062864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123062864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:07:16Z","timestamp":1761026836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123062864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1071358123062864"],"URL":"https:\/\/doi.org\/10.1007\/s12350-019-01755-3","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis\u20142018 update: Japanese Society of Nuclear Cardiology recommendations","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-019-01755-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}